Literature DB >> 19394116

Phenethyl pyridines with non-polar internal substituents as selective ligands for estrogen receptor beta.

Michael Waibel1, Karen J Kieser, Kathryn E Carlson, Fabio Stossi, Benita S Katzenellenbogen, John A Katzenellenbogen.   

Abstract

To create estrogen receptor beta (ERbeta)-selective ligands with improved biological characteristics, we have extended our investigations of structurally simple bibenzyl-core ligands by preparing a series of compounds in which one phenol is replaced by a 3-hydroxypyridine ring. These phenethyl pyridines were obtained by picoline anion alkylation, and compounds with different patterns of alkyl substitution on the central two carbon units were prepared. Binding affinities for ERalpha and ERbeta were determined, and ligands with promising affinities and selectivities for ERbeta were further tested for their gene transcriptional activity. Several compounds had high affinity selectivity and good potency selectivity in transcription assays. This study advances our understanding of compounds having ER-subtype selectivity and will help to direct efforts in developing novel ER ligands.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394116      PMCID: PMC3176332          DOI: 10.1016/j.ejmech.2009.03.013

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  34 in total

1.  Comparative QSAR analysis of estrogen receptor ligands.

Authors:  H Gao; J A Katzenellenbogen; R Garg; C Hansch
Journal:  Chem Rev       Date:  1999-03-10       Impact factor: 60.622

Review 2.  Oestrogen as a neuroprotective hormone.

Authors:  Christian Behl
Journal:  Nat Rev Neurosci       Date:  2002-06       Impact factor: 34.870

Review 3.  The future of the new selective estrogen receptor modulators.

Authors:  Santiago Palacios
Journal:  Menopause Int       Date:  2007-03

4.  Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.

Authors:  S A Beresford; N S Weiss; L F Voigt; B McKnight
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

Review 5.  Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones.

Authors:  J A Katzenellenbogen; B W O'Malley; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1996-02

6.  ER beta: identification and characterization of a novel human estrogen receptor.

Authors:  S Mosselman; J Polman; R Dijkema
Journal:  FEBS Lett       Date:  1996-08-19       Impact factor: 4.124

7.  Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites.

Authors:  Meri De Angelis; Fabio Stossi; Michael Waibel; Benita S Katzenellenbogen; John A Katzenellenbogen
Journal:  Bioorg Med Chem       Date:  2005-08-15       Impact factor: 3.641

8.  Ring nitrogen-substituted non-steroidal estrogens: pyridine and pyrimidine analogs of the phenol in deoxyhexestrol experience resonance constraints on preferred ligand conformation.

Authors:  Meri De Angelis; John A Katzenellenbogen
Journal:  Bioorg Med Chem Lett       Date:  2004-12-06       Impact factor: 2.823

Review 9.  Protective effects of estrogen on the cardiovascular system.

Authors:  Michael E Mendelsohn
Journal:  Am J Cardiol       Date:  2002-06-20       Impact factor: 2.778

Review 10.  Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development.

Authors:  Luigi Gennari; Daniela Merlotti; Fabrizio Valleggi; Giuseppe Martini; Ranuccio Nuti
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.